Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Edmond Emilien Chouinard
Observed names:
E Chouinard,
E. Chouinard,
E.E. Chouinard,
Edmond Chouinard,
Edmond E. Chouinard
Observed institutions:
BC Cancer Agency,
Grand River Hospital,
Ottawa Hospital,
Jewish General Hospital,
Windsor Regional Hospital,
Hôpital du Sacré-Cœur de Montréal,
Cambridge Memorial Hospital,
Novartis (Canada),
McMaster University
show all 9
OpenAlex ID:
A5008312330
Helping Patients Make Informed Choices: A Randomized Trial of a Decision Aid for Adjuvant Chemotherapy in Lymph Node-Negative Breast Cancer
2003
·
T. Whelan
, C. Sawka
, et al.
·
JNCI Journal of the National Cancer Institute
·
229
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial
2023
·
Christopher J Sweeney
, Andrew J Martin
, et al.
·
The Lancet Oncology
·
222
Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2
2014
·
H.S. Rugo
, K.I. Pritchard
, et al.
·
Annals of Oncology
·
134
PDF
Health‐related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO‐2 trial
2013
·
Howard A. Burris
, Fabienne Lebrun
, et al.
·
Cancer
·
105
PDF
Recall bias in case-control studies: An empirical analysis and theoretical framework
1995
·
E. Chouinard
, S. Walter
·
Journal of Clinical Epidemiology
·
65
Data sharing as a national quality improvement program: reporting on BRCA1 and BRCA2 variant-interpretation comparisons through the Canadian Open Genetics Repository (COGR)
2017
·
Matthew S. Lebo
, Kathleen-Rose Zakoor
, et al.
·
Genetics in Medicine
·
31
PDF
An NCIC-CTG phase I dose escalation pharmacokinetic study of the matrix metalloproteinase inhibitor BAY 12-9566 in combination with doxorubicin
2005
·
H. Hirte
, D. Stewart
, et al.
·
Investigational New Drugs
·
7
An NCIC CTG phase I/pharmacokinetic study of the matrix metalloproteinase and angiogenesis inhibitor BAY 12-9566 in combination with 5-fluorouracil/leucovorin
2004
·
R. Goel
, E. Chouinard
, et al.
·
Investigational New Drugs
·
7
Patient-reported physical, emotional, and social functioning in advanced breast cancer: Insights from BOLERO-2.
2013
·
Denise Aysel Yardley
, Gabriel N. Hortobagyi
, et al.
·
Journal of Clinical Oncology
·
5
BOLERO-2: Health-related quality-of-life (HRQoL) in metastatic breast cancer patients treated with everolimus and exemestane versus exemestane.
2012
·
Hope S. Rugo
, J. Thaddeus Beck
, et al.
·
Journal of Clinical Oncology
·
4
Reproducibility of pathological grading in breast cancer
1994
·
E.E. Chouinard
, V. Chen
, et al.
·
The Breast
·
4
Clinical management and resolution of stomatitis in BOLERO-2.
2013
·
Alejandra T. Perez
, Hope S. Rugo
, et al.
·
Journal of Clinical Oncology
·
3
Patient-reported physical, emotional, and social functioning in advanced breast cancer: Insights from BOLERO-2.
2013
·
Denise Aysel Yardley
, Gabriel N. Hortobagyi
, et al.
·
Journal of Clinical Oncology
·
2
Abstract P3-15-02: Treat ER+ight Canadian prospective observational study in HR+ advanced breast cancer: 2nd interim analysis
2018
·
S Dent
, N Califaretti
, et al.
·
Cancer Research
·
1
In patients with cancer who were starting chemotherapy, apixaban reduced VTE and increased major bleeding at 180 d
2019
·
Edmond Chouinard
·
Annals of Internal Medicine
Real-world everolimus experience in postmenopausal HR+ HER2- advanced breast cancer women: Treat ER+ight Canadian prospective observational study 2nd subgroup analysis
2017
·
C. Doyle
, N. Califaretti
, et al.
·
Annals of Oncology
Tamoxifen reduced breast cancer risk but increased risks of thromboembolic events and all cause mortality in women
2003
·
E. Chouinard
·
BMJ Evidence-Based Medicine
Review: palliative chemotherapy reduces death and progression at 12 months in advanced or metastatic colorectal cancer
2001
·
E. Chouinard
·
BMJ Evidence-Based Medicine
Review: Palliative chemotherapy reduces death and progression at 12 months in advanced or metastatic colorectal cancer
2001
·
Edmond Chouinard
·
ACP Journal Club
Raloxifene reduced the incidence of breast cancer in postmenopausal women with osteoporosis
1999
·
Edmond Chouinard
·
ACP Journal Club
NCIC CTG IND 113: two phase I dose escalation pharmacokinetic (PK) studies of BAY 12-9566 (BAY) in combination with either doxorubicin (DOX) or modulated 5-fluorouracil (FU)
1999
·
H. Hirte
, D. Stewart
, et al.
·
European Journal of Cancer
Induced abortion did not increase the risk for breast cancer
1997
·
Edmond E. Chouinard
, Edmond E. Chouinard
·
ACP Journal Club
Show more works
View as search
Works count:
23
Citation count:
819
H-index:
7
I10-index:
6
Year
Topic
Type
